After a 2022 Health Exit, Symbe’s Founders Take on the Enterprise Sale

The London startup, founded by a team with a prior digital health exit, aims to automate the late-stage ROI justification that stalls major deals.

About Symbe

Published

For sales teams closing a six-figure enterprise deal, the final hurdle is often not the product demo but the internal business case. A procurement officer needs a slide to justify the spend to their CFO, a technical lead needs to show ROI to their VP, and the champion needs to align a half-dozen other stakeholders. It is a collaborative, document-heavy process that can stall a deal for weeks. London-based Symbe is betting that an AI platform built for this specific, late-stage bottleneck can become the standard operating procedure for value-based selling.

Founded in 2023, Symbe has raised a total of roughly $5.7 million to date, according to regulatory filings [Investegate, October 2026]. Its core proposition is a collaborative workspace where sales representatives and prospective buyers can jointly build, refine, and approve the financial justification for a purchase. The company reports that more than 2,500 organizations have now used its platform, including named logos like Salesforce, HubSpot, and Stripe [ADVFN, retrieved 2026]. For a team that came together over a shared problem in digital health, this pivot to enterprise sales tools is a deliberate move into another complex, multi-stakeholder workflow.

The Wedge: Collaborative Justification

Symbe’s product is not another CRM or sales engagement platform. It enters the funnel at the point where a deal is nearly won but requires internal sign-off. The platform allows a sales rep to quickly generate a structured business case, pulling in data from integrated CRM and project management tools [SoftwareWorld, retrieved 2026]. The key differentiator, however, is the collaborative layer. Prospects can be invited into a shared "digital showroom" to adjust assumptions, contribute data, and co-author the final proposal [concept.vc, retrieved 2024].

The goal is to turn a static, back-and-forth document process into a dynamic, aligned conversation. Symbe claims this can dramatically accelerate the final stages of a sale. One customer case study reported by the company cited a 2.4x increase in win rate and an 86% prospect collaboration rate [Symbe, retrieved 2024]. While these are company-sourced metrics and not peer-reviewed data, they point to the outcome Symbe is designed to produce: reducing friction and uncertainty in the procurement committee.

A Team Built on Prior Pattern Recognition

The founding team’s background is central to understanding Symbe’s approach. CEO Martin Blinder and COO Thomas Laurbjerg previously co-founded Tictrac, a digital health and employee wellbeing platform that was acquired by Dialogue Health Technologies in 2022 [Dealroom.co, retrieved 2026]. Their experience involved navigating the intricate stakeholder landscapes of corporate wellness programs, which often require buy-in from HR, finance, and department heads.

They are joined by CTO Xavier Wilders, a machine learning specialist who previously founded and exited a budgeting platform for SMEs [Tech.eu, May 2024]. Oliver MacCarthy, a co-founder of Tictrac, is also listed as a founder in Symbe’s later funding announcements, focusing on product design [Investegate, October 2026]. This collective history suggests a team adept at building products that serve complex, regulated, or multi-party decision-making processes,a skill set directly transferable to enterprise sales.

Founder Role Prior Experience
Martin Blinder CEO Co-founded Tictrac (acquired 2022) [Tech.eu, May 2024]
Thomas Laurbjerg COO/CRO Co-founded Tictrac; leads commercial growth [concept.vc, retrieved 2024]
Xavier Wilders CTO Founded Beyond Labs (acquired 2023); ML specialist [Tech.eu, May 2024]
Oliver MacCarthy Head of Product Design Co-founded Tictrac [LinkedIn, retrieved 2026]

Traction and the Road to Regulation

Symbe’s reported growth from over 20 beta customers in mid-2024 to more than 2,500 companies by late 2026 indicates rapid early adoption [FinSMEs, May 2024] [ADVFN, retrieved 2026]. The customer list includes notable SaaS and enterprise software companies, suggesting the platform resonates in its own industry first. The $5.7 million seed round closed in 2026 was led by Kfund, with continued participation from early backers like Concept Ventures and Notion Capital [Investegate, October 2026].

The company’s evolution will likely be measured by its ability to move beyond a point solution for sales teams. Symbe’s materials also mention "value realization" functionalities for post-sale tracking [Symbe, retrieved 2024]. This hints at a broader ambition to own the value management lifecycle, from the initial business case through to proving ongoing ROI after the contract is signed. For regulated industries like healthcare or finance, where justifying software spend is an perpetual exercise, such a tool could become deeply embedded.

The Competitive Counterfactual

Symbe operates in a crowded field of sales tech, but its focused wedge provides some insulation. The primary competitive pressure is not a direct clone, but the inertia of existing workflows. Large enterprises often rely on a patchwork of spreadsheets, slide decks, and internal wikis to build business cases. Displacing these entrenched, if inefficient, methods requires proving that Symbe’s collaborative platform is not just another tool, but a fundamental improvement in process that delivers measurable time-to-close advantages.

  • Integration depth. The platform’s utility is tied to its ability to seamlessly pull live data from CRM, financial, and project management systems. Any friction here reduces its value proposition.
  • Economic sensitivity. In a budget-constrained environment, procurement teams may revert to manual methods, viewing a dedicated business case platform as a discretionary spend itself.
  • Scale of proof. While early metrics are promising, Symbe will need to consistently demonstrate that its platform moves the needle for a broader set of industries and deal sizes beyond its initial tech-centric customer base.

The company’s most plausible answer to these risks is its founding team’s experience. They have previously scaled a B2B software company through an acquisition in a stakeholder-heavy domain. Their playbook likely involves deep customer partnership to refine the product into an indispensable, rather than optional, layer of the enterprise sales stack.

The Next Twelve Months

The immediate focus for Symbe will be converting its thousands of users into a durable, enterprise-grade customer base. Key milestones to watch include a potential Series A round to fuel expansion, especially into the North American market, and the announcement of larger, non-tech enterprise logos. The development of its post-sale value realization features will also be critical in expanding its footprint within existing accounts.

For the sales teams and procurement officers who are its end-users, the standard of care today is a fragmented, manual process. It involves consolidating emails, version-controlling spreadsheets, and scheduling yet another meeting to align on numbers. The disease state is deferred decisions and lost deals due to internal misalignment, not product fit. Symbe’s treatment is a shared, dynamic document that builds consensus by making the value case a collaborative project from the start. Its success will be measured not in features, but in how many enterprise deals it helps cross the finish line.

Sources

  1. [ADVFN, retrieved 2026] Symbe customer and user count | https://uk.advfn.com/stock-market/london/share-news/Symbe/9823419
  2. [concept.vc, retrieved 2024] Symbe portfolio page | https://concept.vc/portfolio/symbe
  3. [Dealroom.co, retrieved 2026] Tictrac acquisition details | https://dealroom.co/companies/tictrac
  4. [FinSMEs, May 2024] Symbe raises £1.2M in Pre-Seed Funding | https://www.finsmes.com/2024/05/symbe-raises-1-2m-in-pre-seed-funding.html
  5. [Investegate, October 2026] Investment in AI-powered enterprise sales platform | https://www.investegate.co.uk/announcement/rns/mindflair--mfai/investment-in-ai-powered-enterprise-sales-platform/9823419
  6. [LinkedIn, retrieved 2026] Oliver MacCarthy profile | https://www.linkedin.com/in/olivermaccarthy
  7. [SoftwareWorld, retrieved 2026] Symbe product overview | https://www.softwareworld.co/symbe-review/
  8. [Symbe, retrieved 2024] Company website and case study | https://www.symbe.co/
  9. [Tech.eu, May 2024] Symbe secures £1.2M Pre-Seed for AI-driven business case creation | https://tech.eu/2024/05/03/symbe-secures-1-2m-pre-seed-for-ai-driven-business-case-creation/

Read on Startuply.vc